Technical skills open doors. Emotional intelligence keeps them open. In every industry, the professionals who rise fastest are not always the most...
Why Emotional Intelligence Trumps Technical Skill
read more
INSIGHTS ON PHARMA INNOVATION, ETHICS, AND LEADERSHIP
Explore thought leadership articles and stories shaping the future.
Latest Insights
What Pharma Can Learn from Consumer Product Launches
Years ago, I released a small music single. I spent days obsessing over the sound, the mix, and the production. When it finally launched, I proudly...
The Subtle Art of Balancing Short-Term Wins with Long-Term Value
Pharma loves a quick win. A fast HTA approval, a glowing headline, a big first-quarter number. But short-term victories can come at a long-term cost...
How to Measure Access Success Beyond Sales Figures
Ask most pharma executives how a launch is going, and they’ll quote sales figures. Revenue is easy to measure and looks impressive on a slide. But...
When “Data-Driven” Decisions Go Wrong — And What to Do
“Data-driven” sounds impressive. It makes strategy sound objective, scientific, and precise. However, being "data-driven" frequently masks another...
Stakeholder Mapping Hacks for Faster Decision-Making
Stakeholder mapping often gets treated like homework. Teams create lists of regulators, payers, clinicians, and patient groups, tick a box, and move...
How Access-First Thinking Can Save Billions in Missed Revenue
Market access has a branding problem. It’s often seen as the administrative stage between regulatory approval and commercial launch. But in truth,...
Why Communication Beats Strategy in Early Adoption
Pharma loves strategy. There are workshops, frameworks, and slides with more arrows than a medieval battlefield. But when it comes to early...
The Future of Patient Access: Lessons from Emerging Markets
When we talk about patient access in Europe or the US, the focus is usually on reimbursement, HTAs, or price negotiations. But in many emerging...
When Digital Tools Fail in Pharma
Pharma’s digital revolution promised transformation. Apps for patients. Dashboards for payers. AI tools to predict outcomes. Yet for every digital...
The Hidden Cost of Misaligned Cross-Functional Teams
If you’ve ever sat in a cross-functional meeting, you’ll recognise the signs. Commercial wants bold claims. Regulatory insists on restraint. Medical...
How Real-World Evidence Can Make or Break a Product
Randomised controlled trials are tidy, logical, and beloved by regulators. But once a product leaves the pristine world of trial centres and meets...
Lessons from Failed Launches That Nobody Publishes
Pharma loves success stories. They fill conferences, case studies, and LinkedIn posts. Yet the most useful lessons often come from the launches that...